Journal History
| 2012 | The inaugural issue was released. Antibiotics was published as a quarterly journal. |
| 2015 | The journal Twitter account was established. |
| 2016 | Antibiotics was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). Antibiotics was indexed in PubMed—National Library of Medicine (NLM), starting with Volume 1 (Issue 1). Antibiotics was indexed in PubMed Central (PMC)—National Library of Medicine (NLM), starting with Volume 1 (Issue 1). Antibiotics was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1). |
| 2017 | Antibiotics announced the first edition of the Travel Award. |
| 2018 | Antibiotics was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). |
| 2019 |
Antibiotics received its first Impact Factor (2.921), ranked 40/89 (Q2) in “Infectious Diseases” and 109/267 (Q2) in “Pharmacology & Pharmacy”. Antibiotics established the following sections: Antibiotics started the Topic Board. |
| 2020 |
Antibiotics received an Impact Factor (3.893), ranked 23/93 (Q1) in “Infectious Diseases” and 64/270 (Q1) in “Pharmacology & Pharmacy”. Antibiotics adopted a monthly publication schedule. Antibiotics started the Reviewer Board. Antibiotics announced the first edition of the Best Paper Award, Reviewer Award and Young Investigator Award. |
| 2021 |
Antibiotics received an Impact Factor (4.639), ranked 26/92 (Q2) in “Infectious Diseases” and 75/275 (Q2) in “Pharmacology & Pharmacy”. Antibiotics established the following sections: The year 2021 marked the 10th Anniversary of Antibiotics. |
| 2023 |
Structures of Bacterial Proteins was merged with Mechanisms of Antibiotic Action to create a new section Mechanisms and Structural Biology of Antibiotic Action. Biochemical and Genetics Studies of Infectious Disease Progression and Intervention was renamed as Genetic and Biochemical Studies of Antibiotic Activity and Resistance. |
| 2025 | Antibiotics received its 2024 Impact Factor (4.6), ranked 17/137 (Q1) in “Infectious Diseases” and 57/352 (Q1) in “Pharmacology and Pharmacy”. The Croatian Pharmacological Society (CPS) became affiliated to Antibiotics. Antibiotics announced the Travel Award and 2024 Best PhD Thesis Award. |
| 2026 | The Northern Greece Society of Medical Biopathology (EIBBE) became affiliated to Antibiotics. Antibiotics received its CiteScore (2025) of 10.2, ranked 4/79 (Q1) in “General Pharmacology, Toxicology and Pharmaceutics”. Antibiotics received its 2025 Impact Factor (5.5), ranked 18/141 (Q1) in “Infectious Diseases” and 56/356 (Q1) in “Pharmacology and Pharmacy”. |
Editor-in-Chief
| 2012–2019 | Editor-in-Chief: Prof. Dr. Christopher C. Butler (Founding Editor) |
| 2019–present | Editor-in-Chief: Prof. Dr. Nicholas Dixon |
Section Editor-in-Chief
| 2019–2022 | Section Editor-in-Chief: Prof. Dr. John E. Gustafson for the section on Mechanism and Evolution of Antibiotic Resistance. |
| 2019–2023 | Section Editor-in-Chief: Prof. Dr. Anthony William Coleman for the section on Mechanism of Antibiotic Action. |
| 2019–2024 | Section Editor-in-Chief: Prof. Dr. Jesus Simal-Gandara for the section on The Global Need for Effective Antibiotics. |
| 2019–2026 | Section Editor-in-Chief: Prof. Dr. Jeffrey Lipman for the section on Pharmacokinetics and Pharmacodynamics of Drugs. |
| 2019–present | Section Editor-in-Chief: Dr. Albert Figueras for the section on Antibiotics Use and Antimicrobial Stewardship. Section Editor-in-Chief: Prof. Dr. Carlos M. Franco for the section on Novel Antimicrobial Agents. Section Editor-in-Chief: Dr. Jean-Marc Sabatier for the section on Antimicrobial Peptides. Section Editor-in-Chief: Prof. Dr. William N. Setzer for the section on Plant-Derived Antibiotics. |
| 2020–present | Section Editor-in-Chief: Prof. Dr. Adelaide Almeida for the section on Bacteriophages. |
| 2021–2023 | Section Editor-in-Chief: Prof. Dr. Aaron J. Oakley for the section on Structures of Bacterial Proteins. |
| 2021–2024 | Section Editor-in-Chief: Prof. Dr. Max Maurin for the section on Antibiotics in Animal Health. |
| 2021–present | Section Editor-in-Chief: Dr. Manuel Simões for the section on Biosynthesis and Combinatorial Approaches in Antimicrobial Discovery. Section Editor-in-Chief: Dr. Wolf-Rainer Abraham for the section on Antibiofilm Strategies. Section Editor-in-Chief: Prof. Dr. Anders Løbner-Olesen for the section on Genetic and Biochemical Studies of Antibiotic Activity and Resistance. |
| 2022–present | Section Editor-in-Chief: Dr. Serena Riela for the section on Antimicrobial Materials and Surface. Section Editor-in-Chief: Dr. Mehran Monchi for the section on Antibiotic Therapy in Infectious Diseases. |
| 2023–2024 | Section Editor-in-Chief: Prof. Dr. Shiping Tian for the section on Fungi and Their Metabolites. |
| 2023–2026 | Section Editor-in-Chief: Prof. Dr. Anthony William Coleman for the section on Mechanisms and Structural Biology of Antibiotic Action. * Prof. Dr. Anthony William Coleman passed away on 18 April 2026. |
| 2024–present | Section Editor-in-Chief: Dr. Krisztina M. Papp-Wallace for the section on Mechanism and Evolution of Antibiotic Resistance. |
| 2025–present | Section Editor-in-Chief: Prof. Dr. Lingli Huang for the section on Antibiotics in Animal Health Section Editor-in-Chief: Dr. Dario Cattaneo for the section on |
Antibiotics - ISSN 2079-6382